🇺🇸 FDA
Pipeline program

GCPGC, Neulasta, Placebo

SNUCPT08_GCPGC

Phase 1 small_molecule completed

Quick answer

GCPGC, Neulasta, Placebo for Healthy is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials